Mr. Niklitschek serves as the Vice President of Operations at Andes Biotechnologies since 2018. He has assumed strategic, operational and business positions in several biotechnology and life sciences companies in Chile and the UK.
Previous to its incorporation to Andes Biotechnologies, Mr. Niklitschek was Chief Operating Officer of Ingalfarma, a company developing medical device solutions for oncology patients; Chief Executive Officer of Kinostics, a diagnostics start-up developing exosomal biomarker technologies; Business Development Collaborator in Zentynel since 2011, gathering 10 years of experience in linking science and technology with national and international companies. He also served as a consultant for the Deallus Group, focused on strategic intelligence for global life science companies.
Mr. Niklitschek holds a Masters in Bioscience Enterprise from the University of Cambridge, UK, and an undergraduate degree in Biotechnology Engineering from the Universidad de Chile.
